STAAR Surgical Company (STAA) Stock Analysis

STAAR Surgical Company (STAA) Stock Analysis — AI Research | MarketCI

STAA

Market Closed

STAAR Surgical Company

NASDAQHealthcare Medical - Instruments & Supplies

1.16K employees

CEO: Warren Foust

Founded: 1992

$28.37

+$0.00(+NaN%)

Market Cap

1.41B

Beta

1.23

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

STAA Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for STAA built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$0.36

AI Price Target

Machine learning • Price prediction

$20.67

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$4.07

Financial Health

Bankruptcy risk assessment

9.89

Quality Score

Financial strength rating

3.00

AI Investment Grade

Deep analysis of filings & news

65.00

Key Investment Highlights

Important factors affecting STAA investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

44.74% Poor

Conditions Met

17.00/38.00

Due Diligence Score

44.74%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions